Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial.
暂无分享，去创建一个
S. Vermeire | G. D'Haens | D. Gaya | L. Peyrin-Biroulet | S. Danese | J. Panés | A. Armuzzi | M. Daperno | M. Lukáš | F. Magro | A. Dignass | M. le Bars | L. Ni | F. Lavie | M. Lahaye | I. Bravatá | M. Löwenberg | M. Nazar